Psychological Health Among Armed Forces Doctors During COVID-19 Pandemic in India.
COVID-19
Doctors
HADS
anxiety
depression
Journal
Indian journal of psychological medicine
ISSN: 0253-7176
Titre abrégé: Indian J Psychol Med
Pays: United States
ID NLM: 7910727
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
entrez:
5
1
2021
pubmed:
6
1
2021
medline:
6
1
2021
Statut:
epublish
Résumé
A pandemic poses a significant challenge to the healthcare staff and infrastructure. We studied the prevalence of anxiety and depressive symptoms among armed forces doctors in India during the COVID-19 pandemic and the factors that contribute to these symptoms. The study was conducted from March 30, 2020, to April 2, 2020, using a self-administered questionnaire questionnaire using the hospital anxiety and depression scale (HADS), which was sent through Google Forms. Responses were received from 769 respondents. Data were analyzed for demographic details and HADS scores using the chi-square test and backward logistic regression. Anxiety and depressive symptoms were seen in 35.2% and 28.2% of the doctors, respectively. In doctors with anxiety symptoms, significant associations were observed with age (20-35 years, 39.4%, P = 0.01), gender (females, 44.6%, P < 0.001), duration of service (0-10 years, 38%, P = 0.03), and clinical versus non-clinical specialties (non-clinical, 41.3%, P < 0.001) as opposed to marital status, education level, and current department of work.In doctors with depressive symptoms, significant associations were observed with age (P = 0.04), clinical versus non-clinical specialties (P < 0.001), duration of service (0-10 years, 30.1%, P = 0.03), and doctoral degree (P = 0.04) as opposed to gender, marital status, education level, and current working department. The study revealed a high prevalence of anxiety and depressive symptoms among armed forces doctors. The main contributing factors are female gender, young age group, non-clinical specialties, and having a doctoral degree.
Sections du résumé
BACKGROUND
BACKGROUND
A pandemic poses a significant challenge to the healthcare staff and infrastructure. We studied the prevalence of anxiety and depressive symptoms among armed forces doctors in India during the COVID-19 pandemic and the factors that contribute to these symptoms.
METHODS
METHODS
The study was conducted from March 30, 2020, to April 2, 2020, using a self-administered questionnaire questionnaire using the hospital anxiety and depression scale (HADS), which was sent through Google Forms. Responses were received from 769 respondents. Data were analyzed for demographic details and HADS scores using the chi-square test and backward logistic regression.
RESULTS
RESULTS
Anxiety and depressive symptoms were seen in 35.2% and 28.2% of the doctors, respectively. In doctors with anxiety symptoms, significant associations were observed with age (20-35 years, 39.4%, P = 0.01), gender (females, 44.6%, P < 0.001), duration of service (0-10 years, 38%, P = 0.03), and clinical versus non-clinical specialties (non-clinical, 41.3%, P < 0.001) as opposed to marital status, education level, and current department of work.In doctors with depressive symptoms, significant associations were observed with age (P = 0.04), clinical versus non-clinical specialties (P < 0.001), duration of service (0-10 years, 30.1%, P = 0.03), and doctoral degree (P = 0.04) as opposed to gender, marital status, education level, and current working department.
CONCLUSION
CONCLUSIONS
The study revealed a high prevalence of anxiety and depressive symptoms among armed forces doctors. The main contributing factors are female gender, young age group, non-clinical specialties, and having a doctoral degree.
Identifiants
pubmed: 33398226
doi: 10.1177/0253717620934037
pii: 10.1177_0253717620934037
pmc: PMC7375358
doi:
Types de publication
Journal Article
Langues
eng
Pagination
374-378Informations de copyright
© 2020 Indian Psychiatric Society - South Zonal Branch.
Références
Int J Behav Med. 2011 Dec;18(4):384-90
pubmed: 21125365
Occup Med (Lond). 2004 Sep;54(6):400-3
pubmed: 15347778
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
J Postgrad Med. 2019 Oct-Dec;65(4):201-206
pubmed: 31204727
Lancet Psychiatry. 2020 Feb;7(2):148-161
pubmed: 31879245
Chin Med J (Engl). 2020 May 5;133(9):1015-1024
pubmed: 32004165
Indian J Public Health. 2010 Oct-Dec;54(4):219-23
pubmed: 21372373
J Affect Disord. 1999 Jan-Mar;52(1-3):153-9
pubmed: 10357028
Eur J Emerg Med. 2005 Feb;12(1):13-8
pubmed: 15674079
J Emerg Med. 1994 Jul-Aug;12(4):559-65
pubmed: 7963406
Singapore Med J. 2017 Nov;58(11):649-655
pubmed: 27526704
PLoS One. 2014 Jul 22;9(7):e103242
pubmed: 25050618
Pak J Med Sci. 2016 Mar-Apr;32(2):294-8
pubmed: 27182226
Br J Anaesth. 2002 Dec;89(6):873-81
pubmed: 12453932
PLoS Med. 2013 Nov;10(11):e1001547
pubmed: 24223526
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
J Clin Psychiatry. 2008 Apr;69(4):617-20
pubmed: 18426258
Can J Psychiatry. 2007 Apr;52(4):233-40
pubmed: 17500304
Front Psychiatry. 2020 Apr 14;11:306
pubmed: 32346373